Nike shares fell 2.4% in the latest session, dragged down by a broader retreat in sportswear and retail names as investors fretted over consumer spending heading into the Christmas quarter. Lululemon and Under Armour were caught in the same downdraft, a reminder that the move was sector-wide rather than the product of fresh company news from Nike itself.
Yet the selling wasn’t purely collateral damage. A newly skeptical research call added a company-specific weight to the stock, and it landed just as another bank was telling clients the opposite.
Two banks, two directions
Wolfe Research initiated coverage of Nike with an “Underperform” rating and a $28 price target, a stance that media reports linked to the pressure on the shares. The firm did not offer a detailed rationale in the coverage cited.
Barclays took the other side of the trade. Analyst Adrienne Yih lifted her price target to $45 from $37 while keeping an “Overweight” rating, saying after a meeting with management that the stock looks close to a bottom. Even so, she stopped short of calling the brand reset complete, waiting for clearer evidence that the turnaround has actually been finished. A floor, in other words, is not the same thing as a proven recovery.
A third skeptical view reaffirmed the same day carried a $25 target, with heightened caution on China trends following a management meeting. The debate, then, stretches beyond valuation and into the trajectory of the business itself.
Should investors sell immediately? Or is it worth buying Nike?
The numbers behind the caution
Those divergent calls sit against a still-contracting top line. Nike reported revenue of $11.21 billion for the first quarter of fiscal 2027, down 4.3% year over year. For the full fiscal year, the company guided to a high-single-digit percentage decline in revenue and put adjusted earnings per share at $1.15–$1.35.
That guidance explains why the bullish case remains conditional. Barclays’ higher target reflects a bet on stabilization, not a claim that an operational turnaround is already in the books — a distinction that matters more than usual with consumer spending worries adding to the mix.
November 16–17 penciled in
Nike has scheduled an investor day for November 16 and 17, with the main presentations to be webcast from roughly 8:30 a.m. Pacific time on the second day. It is the next formal occasion for management to square its own narrative with the split verdict on Wall Street — above all, whether the company can back up hopes of a bottom and how executives frame the trends that skeptics are watching in China.
Until then, the market is left holding two competing pictures: one of a stock nearing a floor, another of a business whose reset has yet to prove itself. The latest pullback captured that tension neatly — a soft sector backdrop, a fresh sell rating, and, on the other side of the ledger, analysts already spotting signs of stabilization.
Ad
Nike Stock: Buy or Sell?! New Nike Analysis from October 24 delivers the answer:
The latest Nike figures speak for themselves: Urgent action needed for Nike investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 24.
Nike: Buy or sell? Read more here...
